Pneumococcal serotypes in children, clinical presentation and antimicrobial susceptibility in the PCV13 era

C Izquierdo, P Ciruela, S Hernández… - Epidemiology & …, 2020 - cambridge.org
The aim was to analyse invasive pneumococcal disease (IPD) serotypes in children aged⩽
17 years according to clinical presentation and antimicrobial susceptibility. We conducted a …

In-depth analysis of pneumococcal serotypes in Belgian children (2015–2018): Diversity, invasive disease potential, and antimicrobial susceptibility in carriage and …

S Desmet, I Wouters, L Van Heirstraeten, P Beutels… - Vaccine, 2021 - Elsevier
Background Changes in serotype distribution have been described after the switch from the
13-valent pneumococcal conjugate vaccine (PCV13) to the 10-valent pneumococcal …

Serotype 3 is a common serotype causing invasive pneumococcal disease in children less than 5 years old, as identified by real-time PCR

L Selva, P Ciruela, C Esteva, MF De Sevilla… - European journal of …, 2012 - Springer
Serotype 3 is one of the most often detected pneumococcal serotypes in adults and it is
associated with serious disease. In contrast, the isolation of serotype 3 by bacterial culture is …

Pediatric invasive pneumococcal disease three years after PCV13 introduction in the national immunization plan—the continued importance of Serotype 3

C Silva-Costa, J Gomes-Silva, L Prados, M Ramirez… - Microorganisms, 2021 - mdpi.com
The introduction of pneumococcal conjugate vaccines PCV7 and PCV13 led to decreases in
incidence of pediatric invasive pneumococcal disease (pIPD) and changes in serotype …

Study of Pediatric Invasive Pneumococcal Disease in the 13-Pneumococcal Conjugated Vaccine Era

M Garrido-Jareño, FJ Roig-Sena, E Pérez-Pérez… - … and Infectious Disease, 2024 - Elsevier
Background Invasive pneumococcal disease (IPD) remains a significant concern among
children under 5, despite vaccination efforts. This study assessed IPD prevalence and …

Distribution of serotypes causing invasive pneumococcal disease in children from high-income countries and the impact of pediatric pneumococcal vaccination

LR Grant, MPE Slack, C Theilacker… - Clinical Infectious …, 2023 - academic.oup.com
Background The introduction and adoption of pneumococcal conjugate vaccines (PCVs)
into pediatric national immunization programs (NIPs) has led to large decreases in invasive …

Molecular epidemiology of paediatric invasive pneumococcal disease in Andalusia, Spain

B de Felipe, PO Pacheco, BC Gallego… - Epidemiology & …, 2022 - cambridge.org
This study aimed to assess the impact of the introduction of pneumococcal conjugate
vaccine 13 (PCV13) on the molecular epidemiology of invasive pneumococcal disease …

Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal …

J Picazo, J Ruiz-Contreras… - Clinical and Vaccine …, 2011 - Am Soc Microbiol
To assess invasive pneumococcal disease (IPD) clinical presentations and relationships
with age and serotype in hospitalized children (< 15 years) after PCV7 implementation in …

Are risk factors associated with invasive pneumococcal disease according to different serotypes?

P Ciruela, N Soldevila, L Selva… - Human Vaccines & …, 2013 - Taylor & Francis
The aim of this study was to investigate risk factors for the most common serotypes of
invasive pneumococcal disease (IPD). A total of 293 IPD cases were analyzed in children …

Characteristics of children with invasive pneumococcal disease after the introduction of the 13-valent pneumococcal conjugate vaccine in England and Wales, 2010 …

A Makwana, C Sheppard, R Borrow, N Fry… - The Pediatric …, 2018 - journals.lww.com
Background: In England and Wales, replacement of childhood 7-valent pneumococcal
conjugate vaccine (PCV7) with a 13-valent vaccine (PCV13) in 2010 was associated with a …